MorphoSys AG

12/11/2021 | Press release | Distributed by Public on 12/11/2021 11:11

​​​​​​​MorphoSys and Incyte Announce Additional Real-World Evidence Results from RE-MIND2 Study of Tafasitamab (Monjuvi(R)) in Combination with Lenalidomide for the Treatment[...]